Conservative management of tubal ectopic pregnancy

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 23, Issue 4, 2009, Pages 509-518

  van Mello, N M ^a   Mol, F ^a   Mol, B W ^a   Hajenius, P J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

conservative management; ectopic pregnancy; expectant management; methotrexate; tubal pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; CHLORHEXIDINE; CHORIONIC GONADOTROPIN; CONJUGATED ESTROGEN; FOLIC ACID; METHOTREXATE; MIFEPRISTONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SODIUM CHLORIDE;

ABDOMINAL BLEEDING; ABORTION; ARTICLE; BONE MARROW DEPRESSION; CLINICAL TRIAL; CONJUNCTIVITIS; CONSERVATIVE TREATMENT; DOSAGE SCHEDULE COMPARISON; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG MEGADOSE; ECTOPIC PREGNANCY; ENTERITIS; EVIDENCE BASED MEDICINE; GASTRITIS; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LIVER FUNCTION TEST; LOW DRUG DOSE; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PREGNANCY OUTCOME; PREGNANCY TEST; PRIORITY JOURNAL; REFERENCE VALUE; SALPINGOSTOMY; SIDE EFFECT; SINGLE DRUG DOSE; STOMATITIS; TERATOGENICITY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UTERINE TUBE PREGNANCY; UTERUS RUPTURE; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; METHOTREXATE; PREGNANCY; PREGNANCY, TUBAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRASONOGRAPHY, PRENATAL;

EID: 67649859251     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2008.12.007     Document Type: Article

References (39)

1. Ankum W.M., Van der Veen, Hamerlynck H.V., et al. Suspected ectopic pregnancy. What to do when human chorionic gonadotropin levels are below the discriminatory zone. J Reprod Med 40 (1995) 525-528
2. Condous G., Okaro E., Khalid A., et al. The use of a new logistic regression model for prediciting the outcome of pregnancies of unknown location. Hum Reprod 19 (2004) 1900-1910
3. Mol B.W., Van der Veen, and Bossuyt P.M. Implementation of probabilistic decision rules improves the predictive values of algorithms in the diagnostic management of ectopic pregnancy. Hum Reprod 14 (1999) 2855-2862
4. Mol B.W.J., Hajenius P.J., Engelsbel S., et al. Serum human chorionic gonadotropin measurement in the diagnosis of ectopic pregnancy when transvaginal sonography is inconclusive. Fertil Steril 70 (1998) 972-981
5. Lund J. Early ectopic pregnancy -comments on conservative treatment. J Obstet Gynaecol of the British Empire 62 (1955) 70-76
6. Ohel G., Katz M., and Blumenthal B. Complete abortion of early ectopic pregnancy. Int J Gynaecol Obstet 17 6 (1980 May) 596-597
7. Mashiach S., Carp H.J.A., and Serr D.M. Non operative management of ectopic pregnancy: a preliminary report. J Reprod Med 27 (1982) 127
8. Korhonen J., Stenman U.H., and Ylöstalo P. Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril 61 (1994) 632-636
9. Hajenius P.J., Mol B.W.J., Ankum W.M., et al. Suspected ectopic pregnancy: expectant management in patients with negative sonographic findings and low serum hCG concentrations. Early Pregnancy: Biol Med 1 (1995) 258-262
10. Elson J., Tailor A., Banerjee S., et al. Expectant mangement of tubal ectopic pregnancy: prediction of succesful outcome using decision tree analysis. Ultrasound in Obstet Gynaecol 23 (2004) 552-556
11. Lang P.F., Makinen J.I., Irjala K.M., et al. Laparoscopic instillation of hyperosmolar glucose vs. expectant management of tubal pregnancies with serum hCG < or = 2500 mIU/mL. Acta Obstet Gynecol Scand 76 8 (1997 Sep) 797-800
12. Egarter C., Kiss H., and Husslein P. Prostaglandin versus expectant management in early tubal pregnancy. Prostaglandins Leukot Essent Fatty Acids 42 (1991) 177-179
13. Korhonen J., Stenman U., and Ylostalo P. Low-dose oral methotrexate with expectant management of ectopic pregnancy. Obstet Gynecol 88 (1996) 775-778
14. Goldstein D.P., Goldstein P.R., Bottomley P., et al. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstet Gynecol 48 3 (1976 Sep) 321-323
15. Bagshawe K.D., Dent J., Newlands E.S., et al. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96 7 (1989 Jul) 795-802
16. Barnhart K., Coutifaris C., and Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother 2 3 (2001 Mar) 409-417
17. Fernandez H., Bourget P., Ville Y., et al. Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration. Fertil Steril 62 (1994) 943-947
18. Hajenius P.J., Engelsbel S., Mol B.W.J., et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 350 (1997) 774-779
19. Natale A., Candiani M., Barbieri M., et al. Pre and post treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol 117 (2004) 87-92
20. Saraj A.J., Wilcox J.G., Najmabadi S., et al. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single dose intramuscular methotrexate with salpingostomy. Obstet Gynecol 92 (1998) 989-994
21. Chotiner H.C. Nonsurgical management of ectopic pregnancy associated with severe hyperstimulation syndrome. Obstet Gynecol 66 (1985) 740-743
22. Tanaka T., Haydshi H., Kutsuzawa T., et al. Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril 37 (1982) 851-852
23. Ory S.J., Alelei L., Villanueva A.L., et al. Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol 154 (1986) 1299-1306
24. Stovall T.G., Ling F.W., and Buster J.E. Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril 51 3 (1989 Mar) 435-438
25. Mol B.W.J., Hajenius P.J., Engelsbel S., et al. The treatment of tubal pregnancy in The Netherlands: an economic evaluation of systemic methotrexate and laparoscopic salpingostomy. Am J Obstet Gynecol 181 (1999) 945-951
26. Nieuwkerk P.T., Hajenius P.J., Ankum W.M., et al. Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients' health related quality of life. Fertil Steril 70 (1998) 511-517
27. Nieuwkerk P.T., Hajenius P.J., Van der Veen, et al. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II patient preferences for systemic methotrexate. Fertil Steril 7 (1998) 518-522
28. El-Sherbiny M.T., El-Gharieb, and Mera I.M. Methotrexate verus laparoscopic surgery for the management of unruptured tubal pregnancy. Middle East Fertil Soc J 8 (2003) 256-262
29. Fernandez H., Yves V.S., Pauthier S., et al. Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility. Hum Reprod 13 (1998) 3239-3243
30. Sowter M.C., Farquhar C.M., Petrie K.J., et al. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. Br J Obstet Gynecol 108 (2001) 192-203
31. Sowter M.C., Farquhar C.M., and Gudex G. An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. Br J Obstet Gynecol 108 (2001) 204-212
32. Alleyassin A., Khademi A., Aghahosseini M., et al. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial. Fertil Steril 85 (2006) 1661-1666
33. Klauser C.K., May W.L., Johnson V.K., et al. Methotrexate for ectopic pregnancy: a randomized single dose compared with multiple dose. Obstet Gynecol 105 (2005) 64S
34. Yalcinkaya T.M., Brown S.E., Mertz H.L., et al. A comparison of 25 mg/m2 vs 50 mg/m2 dose of methotrexate (MTX) for the treatment of ectopic pregnancy (EP). J Soc Gynecol Invest 7 (2000) 179A
35. Gazvani M.R., Baruah D.N., Alfirevic Z., et al. Mifepristone in combination with methotrexate for the medical mangement of tubal pregnancy: a randomized controlled trial. Hum Reprod 13 (1998) 1987-1990
36. Rozenberg P., Chevret S., Camus E., et al. Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotrexate-placebo. Hum Reprod 18 (2003) 1802-1808
37. The practice committee of the American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy. Fertil Steril 86 (2006) 96-102
38. Jurkovic D. Randomised double blind placebo controlled trial of single dose methotrexate versus expectant management in women with tubal ectopic pregnancy. Ongoing study. Controlled trials registration ISRCTN95698259 2005 Sep 1.
39. van Mello N.M., Mol F., Adriaanse A.H., et al. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial. BMC Womens Health 8 (2008) 10